Use of 3D Robotic Ultrasound for In Vivo Analysis of Mouse Kidneys
August 12th, 2021
5.5K views
This protocol demonstrates robotic ultrasound (US) as a practical, cost-effective, and quick alternative to traditional non-invasive image modalities.
Overview
This protocol demonstrates robotic ultrasound (US) as a practical, cost-effective, and quick alternative to traditional non-invasive imaging modalities. It allows novice users to obtain high-quality renal, cardiac, and liver data efficiently.
Key Study Components
Area of Science
- Robotic Ultrasound Imaging
- Non-invasive Imaging Techniques
- Animal Model Studies
Background
- Robotic ultrasound provides a significant advantage in imaging speed and ease of use.
- It eliminates the need to reposition animals or acoustic probes during scans.
- High-quality images can be obtained from multiple subjects in a short time frame.
- Proper preparation of the animal is crucial for optimal imaging results.
Purpose of Study
- To demonstrate the effectiveness of robotic ultrasound in obtaining detailed anatomical data.
- To provide a protocol that novice users can follow for successful imaging.
- To compare imaging results between normal and abnormal kidney conditions.
Methods Used
- Preparation of the animal's skin for ultrasound imaging.
- Use of specific positioning techniques for cardiac and kidney imaging.
- Selection of appropriate imaging settings and transducers.
- 3D scanning and segmentation of kidney and cardiac structures.
Main Results
- High-quality images were successfully obtained from 20 to 30 mice in one hour.
- Significant differences in kidney volume were observed between control and experimental groups.
- 3D visualization techniques enhanced the analysis of anatomical structures.
- Proper hair removal was critical for achieving clear imaging results.
Conclusions
- Robotic ultrasound is a viable alternative to traditional imaging methods.
- The protocol is accessible for novice users, facilitating high-quality data acquisition.
- Future studies can leverage this technique for various applications in animal research.
Frequently Asked Questions
What is robotic ultrasound?
Robotic ultrasound is an imaging technique that uses automated systems to capture high-quality images without the need for manual repositioning.
How long does it take to image multiple mice?
The protocol allows imaging of 20 to 30 mice in about one hour.
What preparations are needed for the animals?
Animals need to have their fur removed from the imaging area to ensure clear ultrasound images.
Can novice users perform this imaging technique?
Yes, the protocol is designed to be user-friendly for novice researchers.
What types of data can be obtained using this method?
The method allows for the acquisition of renal, cardiac, and liver data.
What are the advantages of using robotic ultrasound?
Advantages include speed, ease of use, and the ability to obtain high-quality images without repositioning the subjects.
Executive Industry Relevance
Robotic ultrasound enables high-throughput in vivo imaging of rodent organs, supporting early discovery workflows where rapid phenotypic assessment is critical. The method provides quantitative anatomical data on kidney volume, cardiac function, and structural abnormalities, facilitating target validation and mechanistic de-risking in preclinical models. Its speed, ease of use, and minimal animal handling reduce variability and improve data reproducibility across discovery teams.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying kidney volume changes in disease models.
- Operational Value: Supports functional target validation through non-invasive, repeatable measurements of organ physiology.
- Predictive Value: Enhances portfolio triage by providing early, translatable biomarkers of kidney and cardiac pathophysiology.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems for downstream compound screening via standardized imaging protocols.
- Quantitative Outputs: Generates reproducible volumetric and functional readouts essential for assay standardization.
- Scalability: Enables screening readiness through rapid data collection from 20–30 mice per hour.
Translational & Preclinical Research
- Disease Relevance: Supports translational biomarker alignment by measuring cyst volumes and cardiac function in genetic kidney disease models.
- Preclinical Continuity: Connects discovery findings to preclinical validation through longitudinal, non-invasive monitoring.
- Risk-Adjusted Decisions: Informs advancement choices by reducing mechanistic ambiguity in kidney–heart axis studies.
Pipeline & Workflow Integration
Positioned within the discovery continuum from target hypothesis testing to lead identification, robotic ultrasound provides quantitative anatomical and functional data that inform early go/no-go decisions.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling longitudinal tracking of kidney and cardiac phenotypes.
- Screening: Delivers assay-ready, reproducible imaging data with minimal technical variability.
- Analytics: Provides volumetric, surface area, and cardiac motion measurements that enable cross-group comparisons.
- Translational Research: Connects to preclinical validation through disease-relevant structural and functional endpoints.
- Enterprise Reuse: Functions as a reusable imaging platform across multiple organ systems and disease models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in kidney and cardiac pathophysiology.
- Operational Value: Delivers standardization, reproducibility, and scalability in organ imaging workflows.
- Strategic Value: Improves go/no-go decisions and reduces late-stage biological risk through early phenotypic de-risking.
- Portfolio Impact: Enables risk-adjusted prioritization based on quantitative, translatable organ metrics.
Implementation Considerations
- Requires training in animal handling, ultrasound physics, and image segmentation software.
- Depends on access to robotic ultrasound systems with 3D acquisition and M-mode capabilities.
- Necessitates cross-team standardization of ROI selection, gain settings, and segmentation protocols.
- Involves adaptation considerations for different mouse strains, ages, and disease severities.
- Limited by ultrasound resolution compared to MRI or microCT, restricting subcellular detail.
Biopharma FAQs
Why does null hypothesis testing matter for target validation?
Null hypothesis testing enables rigorous comparison of kidney volume between control and experimental groups, supporting statistical confidence in target engagement and phenotypic effects observed in disease models.
How does independent variable isolation fit the discovery pipeline?
Isolating variables such as genotype or treatment allows researchers to attribute changes in kidney or cardiac measurements to specific interventions, strengthening causal inference in target validation studies.
What quantitative dependent variable measurements enable downstream decisions?
Measurements of total kidney volume, cyst volume, and cardiac motion parameters provide quantifiable endpoints that inform go/no-go decisions and biomarker qualification in preclinical programs.
Why do replication requirements matter for cross-functional collaboration?
Replication ensures consistent imaging results across operators and sites, which is essential for aligning discovery, preclinical, and translational teams on data interpretation and advancement criteria.
What statistical analysis capabilities are required before implementation?
Implementation requires the ability to perform group comparisons, variance analysis, and correlation testing on volumetric and functional outputs to assess significance and reproducibility.
